Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
1:13-cv-01467
Overview
Parties
Defendant
Par Pharmaceutical Inc. Operating Company
Represented By
4 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Novartis AG Operating Company
Represented By
2 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Novartis Pharmaceuticals Corporation Operating Company
Represented By
6 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Novartis Pharma AG Operating Company
Represented By
2 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Counter Defendant
LTS Lohmann Therapie-Systeme AG Operating Company
Represented By
2 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Novartis International Pharmaceutical Ltd. Operating Company
Represented By
2 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
Mylan Pharmaceuticals Inc. et al. v. Novartis AG et al.
Mylan Pharmaceuticals Inc. et al. v. Novartis AG et al.
Noven Pharmaceuticals, Inc. et al. v. Novartis AG et al.
Noven Pharmaceuticals, Inc. et al. v. Novartis AG et al.
Novartis Pharmaceuticals Corporation v. Amneal Pharmaceuticals LLC
Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories, Ltd.
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation v. Alvogen Pine Brook Inc.
Novartis Pharmaceuticals Corporation v. Actavis Inc.
Novartis Pharmaceuticals Corporation v. Watson Laboratories Inc.
Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6335031
TTS containing an antioxidant
|
Filed: 1999-04-14
Issued: 2002-01-01
|
Expired (Term Ended)
Expires: 2019-04-14
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).